4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000030
Chief Executive Officer gave up 3,673 shares (to pay taxes)
- Chief Executive Officer acquired 12,379 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
FOUSE JACQUALYN A · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-04-13 | Exercise or conversion : show line 1 in the form | +12,379 | 54,101 | D | ||
| 2020-04-14 | Shares withheld for taxes : show line 2 in the form | −3,673 | $40.64 | $149,271 | 50,428 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-04-13 | Exercise or conversion : show line 3 in the form Performance share units | −12,379 | 24,759 | D |
Loading xslF345X03/wf-form4_158698236240236.xml…